Ardent Health Inc

News & Events zu Ardent Health Inc (ARDT)

$10.960

-0.030 (-0.27%)Zum Schluss

ARDT-News

ARDT-Events

8/4 16:30

Ardent Health Reports Q2 Revenue of $1.62B

Reports Q2 revenue $1.62B, consensus $1.59B. "As I transition to the CEO role, I'm looking forward to building on the momentum of key initiatives launched during my COO tenure as well as Ardent's strong foundation in attractive, growing markets," said Dave Caspers, President and Chief Executive Officer of Ardent Health. "I see clear opportunities to further improve performance and unlock the full potential of the platform. Our growth strategy remains unchanged, but sharpening operational execution is my highest priority. We are focused on the levers we can control - staffing, contracting, capital allocation, standardization and accountability - while continuing to deliver high-quality care to the patients and communities we serve."

8/4 16:30

Company Confirms FY26 Revenue Outlook of $6.4B to $6.7B

Backs FY26 revenue view $6.4B-$6.7B, consensus $6.44B.

6/3 09:40

Morgan Stanley Maintains Equal Weight Rating on Ardent Health with $12 Price Target

Morgan Stanley notes after Ardent Health announced the appointment of COO Dave Caspers as President and CEO, effective immediately, that the CFO and investor relations team commented that the CEO transition was driven by the board in response to a more challenging macro backdrop for health systems. The firm, which says that Ardent's commentary of softer volumes in Q2 "adds to a growing list of investor concerns in the hospital group," has an Equal Weight rating and $12 price target on the shares.

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Kostenlos starten